Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Long-Term Deferred Tax (2022 - 2023)

Catheter Precision (VTAK) has disclosed Long-Term Deferred Tax for 2 consecutive years, with $26.8 million as the latest value for Q4 2023.

  • On a quarterly basis, Long-Term Deferred Tax rose 207.88% to $26.8 million in Q4 2023 year-over-year; TTM through Dec 2023 was $26.8 million, a 207.88% increase, with the full-year FY2023 number at $26.8 million, up 207.88% from a year prior.
  • Long-Term Deferred Tax was $26.8 million for Q4 2023 at Catheter Precision, up from $8.7 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $26.8 million in Q4 2023 to a low of $8.7 million in Q4 2022.